Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Zeyu Shuang"'
Autor:
Zhenchong Xiong, Lin Yang, Juan Ao, Jiarong Yi, Xiazi Zouxu, Wenjing Zhong, Jikun Feng, Weiling Huang, Xi Wang, Zeyu Shuang
Publikováno v:
Frontiers in Genetics, Vol 12 (2022)
Breast cancer (BC) is the most diagnosed cancer and the leading cause of cancer-related deaths in women. The purpose of this study was to develop a prognostic model based on BC-related DNA methylation pattern. A total of 361 BC incidence-related prob
Externí odkaz:
https://doaj.org/article/1937cdafcd7b41fd960c2db09e70a342
Autor:
Jiarong Yi, Wenjing Zhong, Haoming Wu, Jikun Feng, Xiazi Zouxu, Xinjian Huang, Siqi Li, Zeyu Shuang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Although the tumor microenvironment (TME) plays an important role in the development of many cancers, its roles in breast cancer, especially triple-negative breast cancer (TNBC), are not well studied. This study aimed to identify genes related to the
Externí odkaz:
https://doaj.org/article/e688ca1bd3a44a4b8bed69ee6c945ea9
Autor:
Jiarong Yi, Zeyu Shuang, Wenjing Zhong, Haoming Wu, Jikun Feng, Xiazi Zouxu, Xinjian Huang, Siqi Li, Xi Wang
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Background: Triple-negative breast cancer (TNBC) is not sensitive to targeted therapy with HER-2 monoclonal antibody and endocrine therapy due to lack of ER, PR, and HER-2 receptors. TNBC is a breast cancer subtype with the worst prognosis and the hi
Externí odkaz:
https://doaj.org/article/e2cffddb572a4d2b8b5748dc2e3451fb
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Resection of the primary tumor is recommended for symptom relief in de novo stage IV breast cancer. We explored whether local surgery could provide a survival benefit in these patients and attempted to characterize the population
Externí odkaz:
https://doaj.org/article/daeccdfa037246f6969d35d8d07424b1
Autor:
Yize Mao, Xin Huang, Zeyu Shuang, Guohe Lin, Jun Wang, Fangting Duan, Jianlin Chen, Shengping Li
Publikováno v:
Cancer Medicine, Vol 7, Iss 4, Pp 1285-1296 (2018)
Abstract Cholangiocarcinoma (CCA) is a highly malignant tumor with resistance to radiotherapy alone. Olaparib, a highly potent poly(ADP‐ribose) polymerase (PARP) inhibitor, has been shown to sensitize many types of tumor to radiotherapy. However, t
Externí odkaz:
https://doaj.org/article/713e39381fc94e959a436a140bac6157
Autor:
Yize Mao, Hui Xie, Minyi Lv, Qiuxia Yang, Zeyu Shuang, Feng Gao, Shengping Li, Lina Zhu, Wei Wang
Publikováno v:
Cancer Immunology, Immunotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9254e688b93908f3ff1f348bae52f26
https://doi.org/10.1007/s00262-023-03441-3
https://doi.org/10.1007/s00262-023-03441-3
Autor:
Liping Zhang, Qiaoling Zhong, Lili Han, Lijuan Zhang, Qinghua Luo, Xinhua Xie, Zeyu Shuang, Na Li
Publikováno v:
Journal of Cancer Therapy. 13:605-614
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8391d509c2ddd6b8971789492b93fc44
https://doi.org/10.4236/jct.2022.139053
https://doi.org/10.4236/jct.2022.139053
Autor:
Yize Mao, Xinlei Jiang, Wei Wang, Qiuxia Yang, Weisheng Cheng, Feng Gao, Dejun Fan, Shengping Li, Liqin Li, Zeyu Shuang, Wanming Hu
Publikováno v:
Genomics. 114(1)
A major clinical challenge for treating patients with pancreatic ductal adenocarcinoma (PDAC) is identifying those that may benefit from adjuvant chemotherapy versus those that will not. Thus, there is a need for a robust and convenient biomarker for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::722c1733b929cf38c88a2eb60e03e056
https://pubmed.ncbi.nlm.nih.gov/34863899
https://pubmed.ncbi.nlm.nih.gov/34863899
Autor:
Zeyu Shuang, Xiangsheng Xiao, Jiali Wu, Lijuan Zhang, Jianfu Zhao, Xiaoming Xie, Hailin Tang, Peng Liu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 127, Iss, Pp 110174-(2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::574409dd3b3e3d2d8642e4b02832bd44
http://www.sciencedirect.com/science/article/pii/S0753332220303668
http://www.sciencedirect.com/science/article/pii/S0753332220303668
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
BMC Cancer
BMC Cancer
Background Resection of the primary tumor is recommended for symptom relief in de novo stage IV breast cancer. We explored whether local surgery could provide a survival benefit in these patients and attempted to characterize the population that coul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eba9a361653e8c77e5b46194a74f5bd7
http://link.springer.com/article/10.1186/s12885-018-4767-x
http://link.springer.com/article/10.1186/s12885-018-4767-x